PRA Health Sciences Inc (PRAH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Region:North America

Author(s):

Product Code:GDPH6084D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

October 2018

Total pages

60

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services such as phase I-IV study management, and embedded and functional outsourcing services. It offers solutions in bioanalytical laboratories, biometrics, clinical pharmacology, strategic solutions, post-marketing research, clinical diagnostics, and safety and risk management. PRA spans its expertise in the therapeutic areas of biosimilars, oncology, hematology, respiratory, rare diseases, neurology, infectious diseases, cardio-metabolic and immunology. It caters to pharmaceutical and biotechnology industries. The company has presence in the US, Hong Kong, Russia, India, France, Italy, China, Japan, South Africa, Israel and Colombia among others. PRA is headquartered in Raleigh, North Carolina, the US.

PRA Health Sciences Inc (PRAH)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Products

PRA Health Sciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PRA Health Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

PRA Health Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 10

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 13

Private Equity 13

KKR Completes Acquisition Of PRA International From Genstar Capital 13

KKR Completes Acquisition Of ReSearch Pharma Services From Warburg Pincus 15

Partnerships 17

Care Innovations Enters into Partnership with PRA Health Sciences 17

Delmar Pharma Enters into Agreement with PRA Health Sciences 18

PRA Health Sciences and Takeda Pharma Form Joint Venture 19

PRA Health Sciences Enters into Agreement with Takeda Pharma 20

PRA Health Sciences Enters into Agreement with Alliance for Multispecialty Research 21

ReSearch Pharma Forms Joint Venture With Asklep 22

WuXi PharmaTech To Form Joint Venture With PRA International 23

Equity Offering 24

PRA Health Sciences Prices Public Offering of Shares for USD659.7 Million 24

PRA Health Sciences Prices Public Offering of Shares 26

PRA Health Sciences Raises USD416.3 Million in Public Offering of Shares 27

PRA Health Sciences Raises USD234 Million in Public Offering of Shares 29

PRA Health Sciences Raises USD211.3 Million in Public Offering of Shares 30

PRA Health Sciences Completes IPO for USD351.4 Million 31

Acquisition 33

PRA International Acquires CRI Lifetree For USD77.1 Million 33

PRA Health Sciences Acquires ReSearch Pharma 34

PRA International Acquires ClinStar 35

PRA Health Sciences Inc-Key Competitors 36

PRA Health Sciences Inc-Key Employees 37

PRA Health Sciences Inc-Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Joint Venture 40

Recent Developments 41

Strategy And Business Planning 41

Jan 16, 2018: PRA Health Sciences Opens New Salt Lake City Clinic 41

Financial Announcements 42

Aug 01, 2018: PRA Health Sciences reports second quarter 2018 results and updates full year 2018 guidance 42

Apr 25, 2018: PRA Health Sciences Announces First Quarter 2018 Financial Results 44

Feb 21, 2018: PRA Health Sciences Reports Fourth Quarter 2017 Financial Results 46

Oct 25, 2017: PRA Health Sciences Reports Third Quarter 2017 Results and Updates Full Year 2017 Guidance 48

Aug 07, 2017: PRA Health Sciences Reports Second Quarter 2017 Results and Updates Full Year 2017 Guidance 50

Apr 25, 2017: PRA Health Sciences Reports First Quarter 2017 Results 52

Feb 22, 2017: PRA Health Sciences Reports Fourth Quarter and Full Year 2016 Results and Provides Q1 and Full Year 2017 Guidance 54

Corporate Communications 56

Apr 25, 2018: PRA Health Sciences Announces Senior Management Changes 56

Aug 14, 2017: PRA Health Sciences Announces Appointment of New Director 57

Government and Public Interest 58

Mar 27, 2018: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors 58

Appendix 60

Methodology 60

About GlobalData 60

Contact Us 60

Disclaimer 60


List of Figure

List of Figures

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

PRA Health Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 10


List of Table

List of Tables

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PRA Health Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PRA Health Sciences Inc, Deals By Therapy Area, 2012 to YTD 2018 9

PRA Health Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 10

PRA Health Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

KKR Completes Acquisition Of PRA International From Genstar Capital 13

KKR Completes Acquisition Of ReSearch Pharma Services From Warburg Pincus 15

Care Innovations Enters into Partnership with PRA Health Sciences 17

Delmar Pharma Enters into Agreement with PRA Health Sciences 18

PRA Health Sciences and Takeda Pharma Form Joint Venture 19

PRA Health Sciences Enters into Agreement with Takeda Pharma 20

PRA Health Sciences Enters into Agreement with Alliance for Multispecialty Research 21

ReSearch Pharma Forms Joint Venture With Asklep 22

WuXi PharmaTech To Form Joint Venture With PRA International 23

PRA Health Sciences Prices Public Offering of Shares for USD659.7 Million 24

PRA Health Sciences Prices Public Offering of Shares 26

PRA Health Sciences Raises USD416.3 Million in Public Offering of Shares 27

PRA Health Sciences Raises USD234 Million in Public Offering of Shares 29

PRA Health Sciences Raises USD211.3 Million in Public Offering of Shares 30

PRA Health Sciences Completes IPO for USD351.4 Million 31

PRA International Acquires CRI Lifetree For USD77.1 Million 33

PRA Health Sciences Acquires ReSearch Pharma 34

PRA International Acquires ClinStar 35

PRA Health Sciences Inc, Key Competitors 36

PRA Health Sciences Inc, Key Employees 37

PRA Health Sciences Inc, Other Locations 38

PRA Health Sciences Inc, Subsidiaries 39

PRA Health Sciences Inc, Joint Venture 40

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022